These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20375663)

  • 1. Assessment of endpoints in the pediatric population: congenital heart disease and idiopathic pulmonary arterial hypertension.
    Haworth SG; Beghetti M
    Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S35-41. PubMed ID: 20375663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspective on the optimal endpoints for pulmonary arterial hypertension trials.
    Rubin L; Simonneau G
    Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S43-6. PubMed ID: 20375664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical worsening in trials of pulmonary arterial hypertension: results and implications.
    Galiè N; Simonneau G; Barst RJ; Badesch D; Rubin L
    Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S11-9. PubMed ID: 20375660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of endpoints in pulmonary arterial hypertension associated with connective tissue disease.
    Coghlan JG; Pope J; Denton CP
    Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S27-34. PubMed ID: 20375662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endpoints in pulmonary arterial hypertension: the role of clinical worsening.
    Peacock A; Keogh A; Humbert M
    Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S1-9. PubMed ID: 20375659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary arterial hypertension in childhood].
    Douwes JM; van Loon RL; Roothooft MT; Berger RM
    Ned Tijdschr Geneeskd; 2011; 155(49):A3901. PubMed ID: 22166180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of pulmonary arterial hypertension in children.
    Roofthooft MT; van Loon RL; Berger RM
    Paediatr Respir Rev; 2010 Dec; 11(4):240-5. PubMed ID: 21109183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing effectiveness of pulmonary arterial hypertension therapies in daily practice.
    Sitbon O; Hoeper MM; Simonneau G
    Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S21-6. PubMed ID: 20375661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005.
    van Loon RL; Roofthooft MT; Hillege HL; ten Harkel AD; van Osch-Gevers M; Delhaas T; Kapusta L; Strengers JL; Rammeloo L; Clur SA; Mulder BJ; Berger RM
    Circulation; 2011 Oct; 124(16):1755-64. PubMed ID: 21947294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary arterial hypertension in pediatric age].
    Saji T; Nakayama T; Matsuura H
    Nihon Rinsho; 2008 Nov; 66(11):2193-9. PubMed ID: 19051742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bosentan for pulmonary hypertension and other pulmonary diseases: emerging evidence.
    Frantz RP
    Future Cardiol; 2008 Sep; 4(5):459-68. PubMed ID: 19804340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension.
    Zlupko M; Harhay MO; Gallop R; Shin J; Archer-Chicko C; Patel R; Palevsky HI; Taichman DB
    Respir Med; 2008 Oct; 102(10):1431-8. PubMed ID: 18617379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulmonary arterial hypertension in children: new therapeutic approaches].
    Beghetti M
    Ann Fr Anesth Reanim; 2007 Jun; 26(6):570-5. PubMed ID: 17524605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological serum markers in the management of pediatric pulmonary arterial hypertension.
    Van Albada ME; Loot FG; Fokkema R; Roofthooft MT; Berger RM
    Pediatr Res; 2008 Mar; 63(3):321-7. PubMed ID: 18287971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Seven years of experience in patients with pulmonary arterial hypertension in Ege University Hospital: diagnostic approach of a single center].
    Kayikçioğlu M; Kültürsay H
    Anadolu Kardiyol Derg; 2008 Aug; 8(4):279-85. PubMed ID: 18676304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary arterial hypertension and rheumatic diseases--from diagnosis to treatment.
    Distler O; Pignone A
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 4():iv22-5. PubMed ID: 16980719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of transition from intravenous epoprostenol to oral/inhaled targeted pulmonary arterial hypertension therapy in pediatric idiopathic and familial pulmonary arterial hypertension.
    Melnick L; Barst RJ; Rowan CA; Kerstein D; Rosenzweig EB
    Am J Cardiol; 2010 May; 105(10):1485-9. PubMed ID: 20451700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary arterial hypertension in the pediatric age.
    Donti A; Formigari R; Ragni L; Manes A; Galiè N; Picchio FM
    J Cardiovasc Med (Hagerstown); 2007 Jan; 8(1):72-7. PubMed ID: 17255821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative management of pulmonary arterial hypertension in infants and children--corrected and republished article.
    Galante D
    Curr Opin Anaesthesiol; 2011 Aug; 24(4):468-71. PubMed ID: 21659866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pulmonary arterial hypertension: past, present and future].
    Aytekin M; Caylak E
    Tuberk Toraks; 2010; 58(1):100-7. PubMed ID: 20517738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.